Procurement of Multitron HT Incubator

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

CDER-2026-133237

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6640

Additional Details
Set Aside

NONE

Place of Performance

Beltsville, Maryland, UNITED STATES

SourceSAM
Documents1
The U.S. Food and Drug Administration (FDA), under the Department of Health and Human Services, has issued a Sources Sought notice (Procurement Identifier: CDER-2026-133237) for the procurement of a Multitron HT Incubator. This opportunity is managed by the FDA Office of Acquisition and Grant Services and is intended to identify potential vendors capable of supplying a commercially available incubator shaker system tailored for advanced mammalian cell culture applications. The primary objective of this procurement is to acquire an incubator shaker system that can support mammalian cell culture at production-relevant volumes, ensuring precise control over environmental and agitation parameters. The system must be compatible with existing Chinese Hamster Ovary (CHO) suspension culture processes, a standard in biopharmaceutical research and production. Additionally, the equipment should facilitate the simultaneous processing of multiple culture conditions, offering both sufficient capacity and operational flexibility to meet diverse laboratory needs. Reliability in a laboratory environment is a critical requirement, underscoring the need for robust and consistent performance. The scope of this requirement is strictly limited to the provision of the incubator shaker equipment and any associated services necessary for its installation and operation. It explicitly excludes process development or any modification of existing laboratory protocols. Vendors responding to this notice are expected to clearly demonstrate how their proposed solutions meet each of the specified salient characteristics. This procurement falls under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing), with a Product Service Code of 6640. There are no set-aside restrictions associated with this opportunity, making it open to all qualified vendors. The place of performance is Beltsville, Maryland, United States. Interested parties should note that this is a Sources Sought notice, not a solicitation for bids or proposals. The FDA is seeking information from potential sources to inform its acquisition strategy. The notice remains active, with a response deadline of April 20, 2026, at 16:04. For further information or to submit a response, interested vendors should contact Reagan Davis at [email protected] or by phone at 301-796-0910. Additional details and any attachments related to this opportunity can be accessed via the official SAM.gov posting at https://sam.gov/opp/677080c7787c434699faa6e394642ba3/view. This opportunity is particularly relevant for manufacturers and suppliers of advanced laboratory equipment with proven experience in supporting mammalian cell culture processes. Vendors should ensure their submissions comprehensively address all technical requirements and demonstrate alignment with the FDA’s operational needs.